Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Two appointments at Chimerix

This article was originally published in Scrip

Executive Summary

Chimerix, a US biotechnology company developing antiviral therapeutics, has appointed Timothy King vice-president of clinical operations and Dr Hervé Momméja-Marin vice-president of clinical research. Mr King has more than 20 years' experience managing and directing device and drug development clinical trials, having most recently served as a group director at Quintiles. Dr Momméja-Marin has 20 years' experience of global medical and clinical research in infectious and respiratory disease and clinical medicine. He was previously senior medical director of infectious diseases at the contract research organisation i3 Research.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC009630

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel